Researchers at Marshall University have developed a promising treatment strategy to address overdoses involving fentanyl and the veterinary sedative xylazine, a combination increasingly linked to severe health complications and reduced effectiveness of standard overdose reversal agents.
This article was originally published on MedicalXpress.com